Literature DB >> 214819

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients.

D B Case, S A Atlas, J H Laragh, J E Sealey, P A Sullivan, D N McKinstry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 214819     DOI： 10.1016/0033-0620(78)90025-7

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  48 in total

1.  What is the role of the intrarenal renin-angiotensin system in blood pressure control?

Authors:  J E Hall
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

2.  Low-grade fever after prosthetic valve insertion and captopril therapy: an iatrogenic cause.

Authors:  M C Bialas; H Varley; H G Shetty; P A Routledge
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

Review 3.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

4.  Does captopril lower blood pressure in anephric patients?

Authors:  A J Man in 't Veld; G J Wenting; M A Schalekamp
Journal:  Br Med J       Date:  1979-11-03

5.  Inhibitors of angiotensin I converting enzyme for treating hypertension.

Authors: 
Journal:  Br Med J       Date:  1980-09-06

Review 6.  Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.

Authors:  M Packer
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

7.  Splint renal function after captopril in unilateral renal artery stenosis.

Authors:  G J Wenting; H L Tan-Tjiong; F H Derkx; J H de Bruyn; A J Man in't Veld; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

8.  Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.

Authors:  K O Stumpe; A Overlack; R Kolloch; S Schreyer
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Evidence for participation of kinins in the antihypertensive effect of converting enzyme inhibition.

Authors:  A Overlack; K O Stumpe; M Kühnert; R Kolloch; C Ressel; I Heck; F Krück
Journal:  Klin Wochenschr       Date:  1981-01-15

10.  Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.

Authors:  A J Man in 't Veld; I M Schicht; F H Derkx; J H de Bruyn; M A Schalekamp
Journal:  Br Med J       Date:  1980-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.